Page 272 - ACCCN's Critical Care Nursing

Cardiovascular Alterations and Management 249

33. Cannon CP, Molterno DJ, Every N et al. Implementation of AHCPR guide- 56. Najafi F, Dobson AJ, Jamrozik K. Recent changes in heart failure hospitaliza-
lines for unstable angina in 1996. Unfortunate differences between men and tions in Australia. Eur J Heart Fail 2007; 9: 228–33.
women: results from the GUARANTEE registry. J Am Coll Cardiol 1997; 57. Levy D, Kenchaiah S, Larson M, Benjamin EJ, Kupka MJ et al. Long-term
29(Suppl): 217A. trends in the incidence of and survival with heart failure. N Engl J Med
34. CAPRIE Steering Committee. A randomised controlled trial of clopidogrel 2002;347:1397–1402.
versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 58. Roger VL, Weston SA, Redfeild MM, Hellermann-Homan JP, Killian J et al.
348: 1329–39. Trends in heart failure incidence and survival in a community-based popula-
35. PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/ tion. JAMA 2004; 292: 344–50.
IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial 59. Stewart S, MacIntyre K, Hole DA, Capewell S, McMurray JJV. More malignant
infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management than cancer? Five-year survival following a first admission for heart failure
in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS). New in Scotland? Eur J Heart Fail 2001; 3: 315–22.
Engl J Med 1998; 338: 1488–97. 60. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases:
36. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M et al. Effect of Australian facts. AIHW cat. no. CVD 27. Canberra: AIHW and National Heart
glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and Foundation of Australia; 2004.
surface expression of the leukocyte integrin Mac-1 in acute myocardial 61. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P et al.
infarction. J Am Coll Cardiol 1999; 34: 1420–26. Task force for the diagnosis and treatment of chronic heart failure of the
37. Yusuf S, Wittes J, Friedman L. Overview of results of randomised clinical European Society of Cardiology. Guidelines for the diagnosis and treatment
trials in heart disease II. Unstable angina, heart failure, primary prevention of acute and chronic heart failure 2008 of the European Society of Cardi-
with aspiring, and risk factor modification. JAMA 1988; 260: 2259–63. ology. Eur Heart J 2008; 29: 2388–442.
38. Kaplan K, Davison R, Parker M, Przybylek J, Teagarden JR et al. Intravenous 62. Abraham WT, Krum H. Heart failure: a practical approach to treatment. New
nitroglycerin for the treatment of angina at rest unresponsive to standard York: McGraw Hill Medical; 2007.
nitrate therapy. Am J Cardiol 1983; 51:694–8. 63. Soine L. Heart failure and cardiogenic shock. In: Woods SL, Froelicher ESS,
39. Sacks FM, Pieffer MA, Moye LA, Rouleau JL, Rutherford JD et al. The effect Motzer SU, Bridges EJ, eds. Cardiac nursing, 6th edn. Baltimore: Lippincott,
of pravastatin on coronary events after myocardial infarction in patients with Williams & Wilkins; 2010.
average cholesterol levels. N Engl J Med 1996; 335: 1001–9. 64. Gould M. Chronic heart failure. In: Hatchett R, Thompson D, eds. Cardiac
40. Quinn T, Webster R, Hatchett R. Coronary heart disease: angina and acute nursing: a comprehensive guide. Edinburgh: Churchill Livingstone Elsevier;
myocardial infarction. In: Hatchett R, Thompson D, eds. Cardiac nursing: a 2002.
comprehensive guide. Philadelphia: Churchill Livingston Elsevier; 2002. 65. McMurray JJV, Stewart S. Epidemiology, aetiology, and prognosis of heart
41. Thompson Dr, Bowman GS. Evidence for the effectiveness of cardiac reha- failure. Heart 2000; 83: 596–602.
bilitation. Clin Effect Nurs 1997; 1: 64–75. 66. Driscoll A, Worrall-Carter L, Hare DL, Davidson PM, Riegel B et al. Evidence-
42. Malmberg K, Norhammer A, Wedel H, Ryden L. Glycometabolic state at based chronic heart failure management programs: myth or reality. Qual Safe
admission: important risk marker of mortality in conventionally treated Health Care 2009; 18(6): 450–55.
patients with diabetes mellitus and acute myocardial infarction: long term 67. McAlister FA, Stewart S, Ferrua S, McMurray JJV. Multidisciplinary strategies for
results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial the management of heart failure patients at high risk for readmission: A sys-
Infarction (DIGAMI) study. Circulation 1999; 99: 2626–32. tematic review of randomised trials. J Am Coll Cardiol 2004; 44(4): 810–19.
43. Proctor T, Yarcheski A, Oriscello RG. The relationship of hospital process 68. Whellan DJ, Hasselblad V, Peterson E, O’Connor CM, Schulman KA. Meta-
variables to patient outcome post myocardial infarction. Int J Nurs Stud analysis and review of heart failure disease management randomised con-
1996; 33(2): 121–30. trolled clinical trials. Am Heart J 2005; 149: 722–9.
44. De Jong M. Impact of anxiety on cardiac disease. In: Moser D, Riegel B eds. 69. Phillips CO, Singa RM, Rubin HR, Jaarsma T. Complexity of program and
Cardiac nursing: A companion to Braunwald’s heart disease. St Louis: Saunders clinical outcomes of heart failure disease management incorporating special-
Elsevier; 2008. ist nurse-led heart failure clinics. A meta-regression analysis. Eur J Heart Fail
45. Baker CF, Garvin BJ, Kennedy CW, Polivka BJ. The effect of environmental 2005; 7: 333–41.
sound and communication on CCU patients’ heart rate and blood pressure. 70. Driscoll A, Toia D, Gibcus J, Srivastava PM, Hare DL. Heart Failure Nurse
Res Nurs Health 1993; 16: 415–21. Practitioner clinic: an innovative approach for optimisation of beta-blockers.
46. World Health Organization. Needs and action priorities in cardiac rehabilitation Heart Lung Circulation 2008; 17(1): S13.
and secondary prevention in patients with CHD. Copenhagen: WHO Regional 71. Driscoll A, Davidson P, Clark R, Huang N, Aho Z on behalf of National Heart
Office for Europe; 1993. Foundation consumer resource working group. Tailoring consumer resources
47. Taylor RS, Brown A, Ebrahim S et al. Exercise-based rehabilitation for to enhance self-care in chronic heart failure. ACC 2009; 22(3):133–40.
patients with coronary heart disease: systematic review and meta-analysis of 72. Bennett SJ, Cordes DK, Westmoreland G, Castro R, Donnelly E. Self-care
randomised controlled trials. Am J Med 2004; 116: 682–92. strategies for symptom management in patients with chronic heart failure.
48. Oldridge N, Guyatt G, Jones N, Crowe J, Singer J. Effects on quality of life Nurse Res 2000; 49(3): 139–45.
with comprehensive cardiac rehabilitation after acute myocardial infarction. 73. Riegel B, Carlson VV. A situation-specific theory of heart failure self-care.
Am J Cardiol 1991; 74: 1240–44. J Cardiovasc Nurs 2008; 23(3):190–96.
49. Gulanick M, Berra K. Cardiac rehabilitation. In: Moser D, Riegel B eds. 74. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R et al. Cardiovascular effects
Cardiac nursing: A companion to Braunwald’s heart disease. St Louis: Saunders of continuous positive airway pressure in patients with chronic heart failure
Elsevier; 2008. and obstructive sleep apnoea. N Engl J Med 2003; 348: 1233–41.
50. Santoro GM, Buonamici P. Reperfusion therapy in cardiogenic shock 75. Piepoli MF, Davos C, Francis DP, Coats AJ for the ExTraMATCH Collabora-
complicating acute myocardial infarction. Am Heart J 1999; 138(2:2): tive. Exercise training meta-analysis of trials in patients with chronic heart
S126–38. failure (ExTraMATCH). BMJ 2004: 328(7443); 189–200.
51. Cobb LA, Weaver WD, Fahrenbruch CE, Hallstrom AP, Copass MK, Eber- 76. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe
hardt F, Bode F. Community-based interventions for sudden cardiac death: congestive cardiac failure. Results of the Cooperative North Scandinavian
impact limitations and changes. Circulation 1992; 85(Suppl 1): 98–102. Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–35.
52. Bonnemeier H, Ortak J, Wiegand UK, Eberhardt F, Bode F et al. Accelerated 77. SOLVD Investigators. Effect of enalapril on survival in patients with reduced
idioventricular rhythm in the post-thrombolytic era: incidence, prognostic left ventricular ejection fractions and congestive heart failure. N Engl J Med
implications, and modulating mechanisms after direct percutaneous coro- 1991; 325: 293–302.
nary intervention. Ann Noninvas Electrocardiol 2005; 10(2): 179–87. 78. Opie LH, Pfeffer MA: Inhibitors of angiotensin-converting enzyme, angiote-
53. Wagner GS, Marriott HJL. Marriott’s practical electrocardiography, 10th edn. sin II receptor, aldosterone and renin. In: Opie LH, Gersh BJ, eds. Drugs for
Baltimore: Lippincott, Williams & Wilkins; 2000. the heart, 7th edn. Philadelphia: Saunders; 2009
54. Appel S. Care of patients with complications of acute myocardial infarction. 79. Ailabouni W, Eknoyan G. Nonsteroidal anti-inflammatory drugs and acute
In: Moser D, Riegel B eds. Cardiac nursing: A companion to Braunwald’s heart renal failure in the elderly.A risk-benefit assessment. Drugs Aging 1996; 9(5):
disease. St Louis: Saunders Elsevier; 2008. 341–51.
55. National Heart Foundation of Australia and the Cardiac Society of Australia 80. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F et al. Effects
and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). of controlled-release metoprolol on total mortality, hospitalizations, and
Guidelines for the prevention, detection and management of people with chronic well-being in patients with heart failure: the Metoprolol CR/XL Randomized
heart failure in Australia 2006. Melbourne: National heart Foundation of Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study
Australia; 2006. Group. JAMA 2000;283:1295–302.